D. Herrington, Role of estrogens, selective estrogen receptor modulators and phytoestrogens in cardiovascular protection, CAN J CARD, 16, 2000, pp. 5-9
A large body of evidence suggests chat estrogen may be of benefit in reduci
ng the risk of heart disease in postmenopausal women. The mechanism by whic
h. this benefit is conferred has been the subject of numerous investigation
s. III addition to the well known effects of estrogen on lipids, estrogen e
xerts a number of endothelium-dependent effects related to both vasodilatio
n and nitric oxide metabolism that may have a favourable impact on vascular
health. However, this benefit has not yet been confirmed in randomized cli
nical trials. indeed, the only large trial published to date failed to docu
ment a benefit in women with established heart disease. Recent studies have
shown that estrogen may also have some prothrombotic or proinflammatory ef
fects that may offset other benefits. The extent to which selective estroge
n receptor modulators and phytoestrogens share in the beneficial and potent
ially harmful effects of estrogen is not yet established.